BANP
Basic information
Region (hg38): 16:87949244-88077318
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BANP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 36 | 36 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 36 | 1 | 1 |
Variants in BANP
This is a list of pathogenic ClinVar variants found in the BANP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-87975123-C-T | not specified | Uncertain significance (Nov 25, 2024) | ||
16-87975176-G-A | not specified | Uncertain significance (Mar 29, 2023) | ||
16-87981071-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
16-87981093-G-A | not specified | Uncertain significance (Aug 05, 2024) | ||
16-87984084-A-G | not specified | Uncertain significance (Dec 09, 2024) | ||
16-87984125-A-T | not specified | Uncertain significance (Jul 15, 2021) | ||
16-87984175-C-T | not specified | Uncertain significance (Apr 04, 2024) | ||
16-87984190-G-A | not specified | Uncertain significance (Dec 01, 2022) | ||
16-87984207-A-T | not specified | Uncertain significance (Jan 01, 2025) | ||
16-87984237-C-G | not specified | Uncertain significance (Jan 04, 2024) | ||
16-88004354-A-T | not specified | Uncertain significance (Dec 25, 2024) | ||
16-88004376-C-G | not specified | Uncertain significance (Dec 27, 2022) | ||
16-88006091-G-T | not specified | Uncertain significance (Dec 23, 2024) | ||
16-88006104-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
16-88006107-G-A | not specified | Uncertain significance (May 23, 2023) | ||
16-88006119-T-C | not specified | Uncertain significance (Nov 21, 2023) | ||
16-88006172-G-A | not specified | Uncertain significance (Oct 19, 2024) | ||
16-88006217-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
16-88006228-C-T | Likely benign (Apr 01, 2022) | |||
16-88018464-A-G | Ependymoma | Uncertain significance (Dec 29, 2017) | ||
16-88027562-G-A | Benign (Jul 05, 2018) | |||
16-88027597-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
16-88027645-C-T | not specified | Uncertain significance (Aug 19, 2024) | ||
16-88033109-A-C | not specified | Uncertain significance (Nov 25, 2024) | ||
16-88033121-G-T | not specified | Uncertain significance (Jul 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BANP | protein_coding | protein_coding | ENST00000393207 | 13 | 128075 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.994 | 0.00612 | 125742 | 0 | 5 | 125747 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.43 | 219 | 346 | 0.633 | 0.0000238 | 3370 |
Missense in Polyphen | 107 | 218.25 | 0.49026 | 2107 | ||
Synonymous | -1.49 | 181 | 157 | 1.15 | 0.0000129 | 1000 |
Loss of Function | 4.42 | 3 | 28.4 | 0.106 | 0.00000139 | 291 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000905 | 0.0000904 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000905 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000672 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Controls V(D)J recombination during T-cell development by repressing T-cell receptor (TCR) beta enhancer function. Binds to scaffold/matrix attachment region beta (S/MARbeta), an ATC-rich DNA sequence located upstream of the TCR beta enhancer. Represses cyclin D1 transcription by recruiting HDAC1 to its promoter, thereby diminishing H3K9ac, H3S10ph and H4K8ac levels. Promotes TP53 'Ser-15' phosphorylation and nuclear accumulation, which causes cell cycle arrest (By similarity). {ECO:0000250, ECO:0000269|PubMed:16166625}.;
- Pathway
- Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Regulation of TP53 Activity through Association with Co-factors;Regulation of TP53 Activity;Transcriptional Regulation by TP53
(Consensus)
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- loftool
- 0.0438
- rvis_EVS
- -0.82
- rvis_percentile_EVS
- 11.77
Haploinsufficiency Scores
- pHI
- 0.645
- hipred
- Y
- hipred_score
- 0.783
- ghis
- 0.466
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.986
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Banp
- Phenotype
Gene ontology
- Biological process
- chromatin organization;cell cycle;multicellular organism development;protein localization to nucleus;negative regulation of protein catabolic process;positive regulation of transcription, DNA-templated;regulation of signal transduction by p53 class mediator
- Cellular component
- nucleoplasm;nuclear body
- Molecular function
- p53 binding;DNA binding;protein binding